Company intelligence / Profile preview

First-Tier Biotechnology Partners

Los Angeles, California, United States

Ownership: Private
Development stage: Other

Overview

First-Tier Biotechnology Partners was a life science hedge fund founded in 1995 by Dr. Richard W. Bank. The firm specialized in investments within the biotechnology, pharmaceutical, and medical technology sectors, leveraging Dr. Bank's medical and financial expertise. In 2004, the company was acquired by Lehman Brothers Holdings, Inc., where it was integrated into the Liberty View Health Sciences Fund. During its operation, the firm was known for its focus on healthcare innovation and its role in supporting early-stage medical research and development.

Industry: Investors

Beyond the preview

Go deeper on First-Tier Biotechnology Partners.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on First-Tier Biotechnology Partners.

Explore the full profile